| ID | 1041 |
| Name of the vaccine | Infanrix/Hib |
| Microbe | Bacteria |
| Disease name | Pertussis (Whooping Cough) |
| Name of bacteria | Bordetella pertussis |
| Type of vaccine | Combination |
| Nucleic acid content | DNA |
| Age | 15 months and older |
| Description of the vaccine | DTPa/Hib vaccine. |
| Name of the manufacturer | GlaxoSmithKline |
| Name of the manufacturing country | Canada |
| Year of manufacture | 2008 |
| Clinical Phase status | Approved |
| Bacterial strain | Gram-negative coccobacillus. |
| Efficacy | NA |
| Vaccine formulation | NA |
| Dosage | Single dose of Infanrix mixed with Hiberix. |
| Mechanism of action | NA |
| Route of administration | Intramuscular |
| Indications | NA |
| Export | NA |
| Approval | NA |
| Adjuvant | Aluminium hydroxide |
| Repurposing | For diphtheria, tetanus and Hib. |
| Side effects of vaccine | NA |
| Post vaccination | NA |
| Dose type | Single dose |
| Interspecies transfer | NA |
| PubMed identifier | NA |
| Clinical trial number | NCT00696423 |
| Reference | http://www.violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=584&keywords= |
| Other name | NA |
| Additional Links | NA
|